-
Hotel asset manager settles with SEC over cyber breach misreporting
The charges reflect the SEC’s sustained focus on accurate cybersecurity statements.
-
SEC dings Becton Dickinson $175m for misrepresenting product risks
The company failed to properly inform investors about regulatory challenges it was experiencing with the FDA.
-
SEC charges Kiromic BioPharma for failing to disclose FDA holds
Two former executives were fined, but the company itself will not receive a civil penalty due to its self-reporting.
-
Elanco fined $15m for Reg S-K misrepresentations
Elanco’s use of sales incentives created misleading impressions of customer demand, the SEC stated.
-
SEC charges four companies for underreporting Sunburst data breach damage
The four settlements come nearly one year after the SEC sued SolarWinds for misleading investors about its cybersecurity controls.
-
Carl Icahn and Icahn Enterprises settle with SEC over disclosure rules violations
The agency accused Icahn and his company of failing to disclose billions in shares used to secure personal margin loans.
-
SEC charges Ideanomics and three executives with accounting and disclosure fraud
The SEC settled fraud charges against Ideanomics, its CEO and two former executives for misleading financial reporting and disclosures.
-
Bribes, crypto fraud and unregistered brokers attract SEC charges
In this week’s roundup, we see a mix of charges, including disclosure failings within a donor data management software company.